Back to Results
First PageMeta Content
Acetamides / Influenza / Pandemics / Oseltamivir / Influenza treatment / Zanamivir / Neuraminidase inhibitors / Chemistry / Health


Tamiflu MCC Submission Page 4 Tamiflu MCC Submission Page 4 Tamiflu MCC Submission
Add to Reading List

Document Date: 2014-05-20 20:48:30


Open Document

File Size: 65,50 KB

Share Result on Facebook

City

Melbourne / /

Company

2007 Roche Products (New Zealand) Limited / Roche Products (New Zealand) Limited / WHO Collaborating Centre / Pharma Projects Ltd / /

Continent

Europe / /

Country

Switzerland / United States / United Kingdom / New Zealand / /

Event

Business Partnership / /

Facility

Auckland University / Pharmacy Prescribing / /

IndustryTerm

analyses using health insurance claims data / manufacturing capacity / /

MedicalCondition

respiratory illness / viral infection / influenza infection / very mild influenza / disease / seasonal influenza / influenza A H1N1 / Influenza Surveillance Scheme / influenza A / New Zealand influenza / fever / fatigue / seasonal and avian influenza / infection / cough / influenza / /

Organization

WHO Collaborating Centre for Reference and Research / Clear Government / World Health Organization / European Centre for Disease Control / NHS / Institute for Environmental Science and Research / Auckland University / Medicines Classification Committee / Ministry of Health / FDA Pediatric Advisory Committee / /

Position

appropriate Pharmacist / general practitioner / Pharmacist / Executive / accredited pharmacist / registered pharmacist / /

Product

Tamiflu / /

Technology

Pharmacy protocols / /

SocialTag